Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis

ClinicalTrials.gov ID: NCT00625326

Public ClinicalTrials.gov record NCT00625326. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study of the Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis

Study identification

NCT ID
NCT00625326
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Deltanoid Pharmaceuticals
Industry
Enrollment
321 participants

Conditions and interventions

Interventions

  • COL-121 Drug
  • 50 µg/g Calcipotriene Ointment Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2007
Primary completion
Nov 30, 2008
Completion
May 31, 2009
Last update posted
Apr 26, 2011

2008 – 2009

United States locations

U.S. sites
20
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
East Bay Dermatology Medical Group Fremont California 94538
Dermatology Research Associates Los Angeles California 90045
Skin Surgery Medical Group, Inc. San Diego California 92117
Dermatology Specialists, Inc. Vista California 92083
Cherry Creek Research, Inc. Denver Colorado 80209
Longmont Medical Research Network Longmont Colorado 80501
The Savin Center, PC New Haven Connecticut 06511
International Dermatology Research, Inc. Miami Florida 33144
MedaPhase, Inc. Newnan Georgia 30263
Dermatology Specialists Louisville Kentucky 40202
Michigan Center for Skin Care Research Clinton Township Michigan 48038
Grekin Skin Institute Warren Michigan 48088
Academic Dermatology Associates Albuquerque New Mexico 87106
Northwest Cutaneous Research Specialists Portland Oregon 97210
Philadelphia Institute of Dermatology Flourtown Pennsylvania 19034
DermResearch, Inc. Austin Texas 78759
Dermatology Associates of San Antonio San Antonio Texas 78258
Dermatology Research Center Salt Lake City Utah 84124
The Education & Research Foundation, Inc. Lynchburg Virginia 24501
Premier Clinical Research Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00625326, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2011 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00625326 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →